Jim Cramer updated our Bullpen during the April Monthly Meeting on Thursday, adding two stocks and removing several names. The Bullpen is the watchlist of stocks the Club monitors which could, under the right circumstances, join the Charitable Trust. Bullpen stocks are not a part of the portfolio and there’s no guarantee of when, or if, we’ll initiate a purchase. Still, the team likes to keep a separate list of investment ideas to bat around. Consider this a spring cleaning. Additions ARM Holdings : We’re bullish on the British semiconductor company after it introduced its first in-house chip last month, with Meta Platforms as its first customer. Jim forecasts the AGI CPU will soon be in many tech devices and sees the stock as undervalued at $161 per share. If we weren’t in an overbought market, Jim said we would consider an initiation. FedEx : The shipping giant is a must-watch even after its roughly 30% rally this year. Jim still views the stock as “dramatically undervalued,” especially as the company spins off its less-than-truckload shipping unit, called FedEx Freight, which is expected to be completed by June 1. Spin-offs tend to create more value for shareholders. Jim also praised CEO Raj Subramaniam for doing a great job of navigating an increasingly competitive business environment. Keepers Sempra : This diversified utility and energy infrastructure company is a “growth utility” stock that pulled back after an underwhelming quarter. Still, shares are up more than 8% year to date, and its 2.75% dividend yield is a bonus. Jim said he’d buy it when the timing is right. RTX Corporation : The Raytheon parent could benefit from President Donald Trump’s push for major defense contractors to ramp up production of weapons and munitions to replenish military stockpiles. At the same time, we have Boeing in the portfolio, so it wouldn’t make sense to own both names (RTX also owns engine maker Pratt & Whitney and Collins Aerospace, which develops flight-control systems and other airplane parts). Jim said he prefers to wait until RTX reports its first-quarter results on April 21 before making a decision. Solstice Advanced Materials : We exited our position in this specialty chemical company in early January, after its spin-off from Club Holding Honeywell on Oct. 30. Jeff likes to monitor the stock because of the company’s strong position as the only commercial facility for uranium conversion in the U.S., which could give it a boost from higher oil prices. Removals Airbnb : This online platform for short-term rentals is “too episodic,” Jim said, suggesting that while it tends to deliver on earnings and forecast solid growth, there are better ways to play consumer travel. Marvell Technology : The former Club name and leader in custom chips has had an incredible 57% rally so far in 2026, which is precisely why Jim sees this as an unviable stock to purchase right now. He said we missed our chance to jump in. Novartis : This Swiss drugmaker is a strong performer, but since we just initiated a position in Johnson & Johnson , we don’t need a competitor in the portfolio. Intuitive Surgical : This manufacturer of robotic surgical systems recently reported a downbeat quarter. Jim didn’t feel confident in the name after listening to the conference call and called the stock a “dead duck.” Intuitive Surgical also conflicts with our recent initiation of Johnson & Johnson, which is seeking to enter the robotic surgery market. Dell Technologies : Another example of a stock that Jim said he waited too long to buy and eventually got away. It’s now up 52% year-to-date, and Jim isn’t confident it will come down anytime soon, given its transformation from a computer maker to a key AI infrastructure provider. Kimberly-Clark : We’re not currently interested in adding another consumer staples stock, given that we already own best-in-breed names, such as Procter & Gamble and retailer Costco . Nucor : This steel company is a “secular growth stock in an industry that is a cyclical business, therefore it attracts a lot of money,” Jim said. The stock has been on a run and, at $192, is just four bucks off its 52-week high set on Feb. 11. We’d find it more attractive if the share price were to come down, so after further discussion post-meeting, we decided to remove it from the Bullpen at this point. See here for a full list of the stocks in Jim Cramer’s Charitable Trust. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust’s portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
We’re adding 2 new names to the Bullpen — and removing several stocks
